Report Detail

The Global Biologics Market is expected to grow from USD 228,563.24 Million in 2018 to USD 317,569.24 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.81%.

The positioning of the Global Biologics Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market including are AbbVie Inc., Amgen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novo Nordisk A/S, Pfizer Inc., and Sanofi SA.

On the basis of Product, the Global Biologics Market is studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines.

On the basis of Application, the Global Biologics Market is studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on Biologics offered by the key players in the Global Biologics Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Biologics Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Biologics Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Biologics Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Biologics Market

The report answers questions such as:
1. What is the market size of Biologics market in the Global?
2. What are the factors that affect the growth in the Global Biologics Market over the forecast period?
3. What is the competitive position in the Global Biologics Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Biologics Market?
5. What are the opportunities in the Global Biologics Market?
6. What are the modes of entering the Global Biologics Market?


1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research & Forecasting

  • 2.1. Research Methodology
    • 2.1.1. Research Process
    • 2.1.2. Research Framework
    • 2.1.3. Research Reliability & Validity
    • 2.1.4. Research Assumptions
  • 2.2. Forecasting Methodology
  • 2.3. Research Outcome
    • 2.3.1. Competitive Strategic Window
      • 2.3.1.1. Leverage Zone
      • 2.3.1.2. Vantage Zone
      • 2.3.1.3. Speculative Zone
      • 2.3.1.4. Bottleneck Zone
    • 2.3.2. FPNV Positioning Matrix
      • 2.3.2.1. Quadrants
      • 2.3.2.1.1. Forefront
      • 2.3.2.1.2. Pathfinders
      • 2.3.2.1.3. Niche
      • 2.3.2.1.4. Vital
      • 2.3.2.2. Business Strategy
      • 2.3.2.2.1. Business Growth
      • 2.3.2.2.2. Industry Coverage
      • 2.3.2.2.3. Financial Viability
      • 2.3.2.2.4. Channel Support
      • 2.3.2.3. Product Satisfaction
      • 2.3.2.3.1. Value for Money
      • 2.3.2.3.2. Ease of Use
      • 2.3.2.3.3. Product Features
      • 2.3.2.3.4. Customer Support

      3. Executive Summary

      • 3.1. Outlook in the Biologics Market
      • 3.2. Opportunities in the Biologics Market
      • 3.3. Geographical Analysis in the Biologics Market

      4. Premium Insight

      • 4.1. Market Connectivity
      • 4.2. Market Dynamics
        • 4.2.1. Drivers
          • 4.2.1.1. Attractive investment in the market from players
          • 4.2.1.2. Rising prevalence of chronic diseases
          • 4.2.1.3. Patent loss of leading biologic drugs
          • 4.2.1.4. Availability of advanced diagnostics and rising government initiatives in healthcare
        • 4.2.2. Restraints
          • 4.2.2.1. Stringent regulatory process coupled with high capital investment
        • 4.2.3. Opportunities
          • 4.2.3.1. Higher acceptability for innovative therapies
          • 4.2.3.2. Technological advancements in research and development across the globe
        • 4.2.4. Challenges
          • 4.2.4.1. Tightly controlled atmospheric conditions and maintained production process
          • 4.2.4.2. Cost associated with access of biologics
      • 4.3. Porter’s Five Forces Analysis
        • 4.3.1. Threat of New Entrants
        • 4.3.2. Threat of Substitutes
        • 4.3.3. Bargaining Power of Customers
        • 4.3.4. Bargaining Power of Suppliers
        • 4.3.5. Industry Rivalry
      • 4.4. Industry Trends

      5. Global Biologics Market, by Product

      • 5.1. Overview
      • 5.2. Market Sizing & Forecasting
      • 5.3. Cellular Based Biologics
      • 5.4. Gene Based Biologics
      • 5.5. Monoclonal Antibodies
      • 5.6. Recombinant Hormones/Proteins
      • 5.7. Vaccines

      6. Global Biologics Market, by Application

      • 6.1. Overview
      • 6.2. Market Sizing & Forecasting
      • 6.3. Autoimmune Diseases
      • 6.4. Cancer
      • 6.5. Infectious Diseases
      • 6.6. Rare Diseases

      7. Global Biologics Market, by Geography

      • 7.1. Americas
        • 7.1.1. Overview
        • 7.1.2. Market Sizing & Forecasting
        • 7.1.3. Argentina
        • 7.1.4. Canada
        • 7.1.5. Mexico
        • 7.1.6. United States
      • 7.2. Asia-Pacific
        • 7.2.1. Overview
        • 7.2.2. Market Sizing & Forecasting
        • 7.2.3. Australia
        • 7.2.4. China
        • 7.2.5. India
        • 7.2.6. Japan
      • 7.3. Europe, Middle East & Africa
        • 7.3.1. Overview
        • 7.3.2. Market Sizing & Forecasting
        • 7.3.3. France
        • 7.3.4. Germany
        • 7.3.5. Italy
        • 7.3.6. Spain
        • 7.3.7. United Kingdom

      8. Competitive Landscape

      • 8.1. FPNV Positioning Matrix for Global Biologics Market
      • 8.2. Market Vendor Ranking Analysis for Global Biologics Market
      • 8.3. Competitive News Feed Analysis for Global Biologics Market

      9. Company Usability Profiles

      • 9.1. AbbVie Inc.
        • 9.1.1. Overview
        • 9.1.2. Strategy
        • 9.1.3. SWOT
      • 9.2. Amgen, Inc.
        • 9.2.1. Overview
        • 9.2.2. Strategy
        • 9.2.3. SWOT
      • 9.3. Eli Lilly and Company
        • 9.3.1. Overview
        • 9.3.2. Strategy
        • 9.3.3. SWOT
      • 9.4. F. Hoffmann-La Roche AG
        • 9.4.1. Overview
        • 9.4.2. Strategy
        • 9.4.3. SWOT
      • 9.5. GlaxoSmithKline PLC
        • 9.5.1. Overview
        • 9.5.2. Strategy
        • 9.5.3. SWOT
      • 9.6. Johnson & Johnson
      • 9.7. Merck & Co.
      • 9.8. Novo Nordisk A/S
      • 9.9. Pfizer Inc.
      • 9.10. Sanofi SA

      10. Appendix

      • 10.1. Discussion Guide
      • 10.2. Top Reports
        • 10.2.1. Global Wireless Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
        • 10.2.2. Global Smart TV Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
        • 10.2.3. Global Head-Up Display Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
        • 10.2.4. Global Fall Detection System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Summary:
Get latest Market Research Reports on Biologics. Industry analysis & Market Report on Biologics is a syndicated market report, published as Global Biologics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025. It is complete Research Study and Industry Analysis of Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,499.00
$5,499.00
$6,499.00
3,576.71
4,371.71
5,166.71
4,161.58
5,086.58
6,011.58
703,733.58
860,153.58
1,016,573.58
375,801.47
459,331.47
542,861.47
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report